Advertisement
Screener

EXACT SCIENCES CORP Forms 3, 4 and 5: Stock Options, 2009

EXACT SCIENCES CORP Forms 3, 4 and 5: Stock Options

Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 26 rows in 2009. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.

  • 2009-10-26: Reporting owner Berger Barry M; Form 3; Security Stock Option; Transaction Holding.
  • 2009-10-26: Reporting owner Berger Barry M; Form 3; Security Stock Option; Transaction Holding.
  • 2009-10-26: Reporting owner Berger Barry M; Form 3; Security Stock Option; Transaction Holding.
  • 2009-10-26: Reporting owner Berger Barry M; Form 3; Security Stock Option; Transaction Holding.
Transaction dateReporting ownerFormSecurityTransactionSharesPricePrice that dayFiling
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$7.93
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$6.78
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$7.72
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$3.61
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$4.22
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$2.61
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$2.77
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$2.90
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$1.83
exercise price
2009-10-26
2009-10-26
holding as of filing
Berger Barry M
Officer (Chief Medical Officer)
3Stock Option
Derivative · Direct
Holding$1.43
exercise price
2009-10-26
2009-08-03LIDGARD GRAHAM PETER
Officer (SVP, Chief Scientific Officer)
4Stock Option (right bo buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+600,000
600,000 owned after
$2.88
exercise price
2009-08-05
2009-03-31Carelli Charles R Jr
Officer (SVR, CFO, Treasurer & Secretar)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−100,000
0 owned after
$0.042009-07-21
2009-03-31Carelli Charles R Jr
Officer (SVR, CFO, Treasurer & Secretar)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−75,000
0 owned after
$0.042009-07-21
2009-03-31Carelli Charles R Jr
Officer (SVR, CFO, Treasurer & Secretar)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−25,000
0 owned after
$0.042009-07-21
2009-03-31Carelli Charles R Jr
Officer (SVR, CFO, Treasurer & Secretar)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−25,000
0 owned after
$0.042009-07-21
2009-03-31Carelli Charles R Jr
Officer (SVR, CFO, Treasurer & Secretar)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−30,000
0 owned after
$0.042009-07-21
2009-03-31Carelli Charles R Jr
Officer (SVR, CFO, Treasurer & Secretar)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−20,000
0 owned after
$0.042009-07-21
2009-03-31LUBER JEFFREY R
Director, Officer (President and CEO)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−250,000
0 owned after
$0.062009-07-21
2009-03-31LUBER JEFFREY R
Director, Officer (President and CEO)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−75,000
0 owned after
$0.062009-07-21
2009-03-31LUBER JEFFREY R
Director, Officer (President and CEO)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−30,000
0 owned after
$0.062009-07-21
2009-03-31LUBER JEFFREY R
Director, Officer (President and CEO)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−20,000
0 owned after
$0.062009-07-21
2009-03-31LUBER JEFFREY R
Director, Officer (President and CEO)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−60,000
0 owned after
$0.062009-07-21
2009-03-31LUBER JEFFREY R
Director, Officer (President and CEO)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−80,000
0 owned after
$0.062009-07-21
2009-03-31LUBER JEFFREY R
Director, Officer (President and CEO)
4Stock Option (right to buy)
Derivative · Direct
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)−50,000
0 owned after
$0.062009-07-21
2009-03-18Conroy Kevin T
Director, Officer (Vice President)
4Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+2,500,000
2,500,000 owned after
$0.83
exercise price
2009-03-20
2009-03-18ARORA MANEESH
Officer (Vice President)
4Stock Option (right to buy)
Derivative · Direct
A Grant, award or other acquisition pursuant to Rule 16b-3(d)+1,250,000
1,250,000 owned after
$0.83
exercise price
2009-03-20